PDT Partners’s Genesis Healthcare, Inc. GEN Stock Holding History

PDT Partners’s Portfolio GEN Stock Details GEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-19,900	Closed	-$53K	–	594
2017 Q1	$53K	Buy	+19,900	New	+$71.5K	﹤0.01%	465

Other funds holding GEN

CPA

Columbia Pacific Advisors Seattle, Washington $31M AUM 29.53% 1-Year Est. Return

HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

PAM

Panagora Asset Management Boston, Massachusetts $26.7B AUM 36.4% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Forward Management San Francisco, California $907M AUM 0.46% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

PDT Partners's GEN Position: Q2 2017 in Review

PDT Partners sold out of Genesis Healthcare, Inc. (GEN) in Q2 2017, closing a stake of 19,900 shares — an estimated $53K sold.

PDT Partners first reported a position in GEN in Q1 2017 and held it in 1 quarter. The position peaked at $53K in Q1 2017. 75 funds tracked by Wall St. Rank hold GEN as of Q2 2017.

PDT Partners reported no remaining Genesis Healthcare, Inc. position as of Q2 2017 after selling out during the quarter.
PDT Partners sold 19,900 Genesis Healthcare, Inc. shares in Q2 2017, an estimated $53K.
PDT Partners first reported a position in Genesis Healthcare, Inc. in Q1 2017 and held it in 1 quarter.
PDT Partners's Genesis Healthcare, Inc. position peaked at $53K in Q1 2017.
75 funds tracked by Wall St. Rank held Genesis Healthcare, Inc. as of Q2 2017.

Based on PDT Partners's 13F filing for Q2 2017, filed 14 Aug 2017.